Want to see INDP full AI Analyst Report?
Indaptus Therapeutics (INDP) Ratios
580 Followers
Indaptus Therapeutics Ratios
INDP's free cash flow for Q2 2026 was $-1.93M. For the 2026 fiscal year, INDP's free cash flow was increased by $0.00 and operating cash flow was $-1.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 |
| Quick Ratio | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 |
| Cash Ratio | 1.38 | 1.71 | 4.82 | 2.80 | 8.50 |
| Solvency Ratio | -3.39 | -4.43 | -5.42 | -4.17 | -1.65 |
| Operating Cash Flow Ratio | -2.41 | -3.63 | -4.83 | -3.81 | -2.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 3.15M | $ 3.22M | $ 11.15M | $ 23.81M | $ 35.71M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.02 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.95 | 1.86 | 1.24 | 1.14 | 1.13 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.02 | 0.01 | 0.04 |
| Net Debt to EBITDA | 0.41 | 0.38 | 0.81 | 0.64 | 5.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 105.12% | 97.76% | 94.17% | 96.06% | 99.77% |
| Return on Assets (ROA) | -223.94% | -204.69% | -103.35% | -51.04% | -19.00% |
| Return on Equity (ROE) | -661.54% | -380.80% | -127.71% | -58.15% | -21.48% |
| Return on Capital Employed (ROCE) | -629.32% | -389.51% | -134.80% | -60.54% | -21.49% |
| Return on Invested Capital (ROIC) | -629.32% | -381.38% | -133.68% | -60.34% | -21.43% |
| Return on Tangible Assets | -223.94% | -204.69% | -103.35% | -51.04% | -19.00% |
| Earnings Yield | -741.58% | -6.81% | -3.73% | -4.27% | -1.18% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -15.34 | -1.32 | -1.60 | -1.58 | -2.76 |
| Free Cash Flow Per Share | -15.34 | -1.32 | -1.60 | -1.60 | -2.76 |
| Dividend Paid and CapEx Coverage Ratio | -3705814.00 | 0.00 | 0.00 | -75.79 | -2929.56 |
| Capital Expenditure Coverage Ratio | -3705814.00 | 0.00 | 0.00 | -75.79 | -2929.56 |
| Operating Cash Flow Coverage Ratio | 0.00 | -146.42 | -76.58 | -162.48 | -66.68 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -527.25% | -5.59% | -3.24% | -3.95% | -1.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.13 | -14.65 | -26.84 | -23.42 | -84.66 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.89 | 55.92 | 34.28 | 13.62 | 18.19 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.19 | -17.90 | -30.88 | -25.31 | -57.80 |
| Price-to-Operating Cash Flow Ratio | -0.19 | -17.90 | -30.88 | -25.65 | -57.82 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 1.17 | -4.22 | 2.77 | -0.45 |
| Enterprise Value Multiple | 0.27 | -14.31 | -24.47 | -21.86 | -79.44 |
| Enterprise Value | -5.70M | 214.91M | 400.81M | 325.90M | 613.90M |
| EV to EBITDA | 0.27 | -14.31 | -24.47 | -21.86 | -79.44 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | 0.38 | -17.44 | -29.90 | -24.59 | -54.35 |
| EV to Operating Cash Flow | 0.38 | -17.44 | -29.90 | -24.92 | -54.37 |
| Tangible Book Value Per Share | 3.26 | 0.42 | 1.44 | 2.98 | 8.78 |
| Shareholders’ Equity Per Share | 3.26 | 0.42 | 1.44 | 2.98 | 8.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -21.58 | -1.61 | -1.84 | -1.73 | -1.89 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.94 | 0.96 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.71 | 0.82 | 0.87 | 0.91 | 1.46 |
Currency in USD
